Tessera Therapeutics
Pre-clinicalTessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the…
Founded
2018
Focus
Genetics & Genomics
About
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the…
Funding History
4Total raised: $660M
Series C$300MSoftBank Vision Fund 2Jun 15, 2022
Series B$230MSoftBank Vision Fund 2Jun 15, 2021
Series A$80MFlagship PioneeringJun 15, 2020
Seed$50MFlagship PioneeringJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile